Cerus (CERS) Tops Q3 EPS by 2c, offers product revenue guidance

Cerus (NASDAQ: CERS) reported Q3 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $64 million versus the consensus estimate of $63.25 million.

Guidance

The Company continues to expect full-year 2026 product revenue to be in the range of $229 million to $231 million, reflecting growth of 11% to 12% from 2025. Included in this range is full-year 2026 IFC revenue guidance of $23 million to $25 million.

For earnings history and earnings-related data on Cerus (CERS) click here.

You May Also Be Interested In

• Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
• People Incorporated (PPLI) Misses Q3 EPS by 896c
• aTyr Pharma (LIFE) Reports Q3 EPS of $0.53; Offers Guidance